f.kimani
TL2 Moderator · Utrecht
Contributes reviews on supplier material. Based in Utrecht.
Joined 18 December 2024 · last posted 1h
87Posts here
0Topics
0Solutions
1.8kLikes received
1.6kLikes given
21Badges
243Days visited
4.7kPosts read
Recent activity
Full stream-
Revisiting: The best-written scientific paper you have read Replied, post #122 · Lounge › Off topic · 28 Jul 2026 · 19 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Coming back to: Payment method and the leverage it gives you, ranked Replied, post #27 · Sourcing › Payments · 26 Jul 2026 · 25 likes Recurring billing: if a supplier sets up recurring billing by default, understanding the terms for cancellation is important before the first charge.
-
How shortages have affected compounding permissions — does this still hold? Replied, post #31 · Access › Shortages · 25 Jul 2026 · 0 likes Supply interruptions: official shortage notices are published by regulatory agencies. That is the correct primary source rather than pharmacy rumors or forum discussion.
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #49 · Start Here › Welcome · 16 Jul 2026 · 0 likes There is no stupid-questions rule and no penalty for asking badly. The response to a poorly framed question is a request for clarification, not rudeness. That is a…
-
About the Receptor biology category Replied, post #11 · Pharmacology › Receptor biology · 7 Jul 2026 · 29 likes Glucagon receptor agonism: glucagon receptor agonism increases energy expenditure and promotes hepatic fat oxidation. The mechanism is distinct from GLP-1 and GIP…
-
An 18-month record including the parts that went badly Replied, post #55 · Outcomes › Progress reports · 30 Jun 2026 · 0 likes Rate of change: reporting progress as "lost 5 kg in 12 weeks" is more useful than "currently at 82 kg" because the rate tells you whether the change is steady,…
-
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #36 · Pharmacology › Pharmacokinetics · 28 Jun 2026 · 16 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Second pass at: When your prescriber and the evidence disagree Replied, post #41 · Clinical › Prescriber conversations · 26 Jun 2026 · 13 likes On post #37 — agreed on the reasoning, with one qualification. How to ask for what you need: rather than "should I take this", frame it as "I understand the evidence…
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #15 · Practice › Side effects · 26 Jun 2026 · 7 likes Recognition and grading: nausea ranges from "noticeable" to "limiting". Constipation ranges from mild to severe. Having language to describe the magnitude helps you…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #72 · Start Here › How to Ask · 26 Jun 2026 · 0 likes Disagreement-style questions: "I read this and it contradicts what I heard here, which is right?" is answerable. "Is this a bad idea?" without giving the context is not.
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #32 · Access › International · 23 Jun 2026 · 9 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #9 · Practice › Side effects · 22 Jun 2026 · 18 likes Constipation: common, manageable, and frequently under-reported because it is not dramatic. Increasing fibre and fluid intake helps. Over-the-counter management is…